Clinical trials
Terminated Phase 1 Rhabdomyosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AeRang Kim | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Mayo Clinic | 1 |
| National Cancer Institute (NCI) | 1 |
| Novartis Pharmaceuticals | 1 |
| Y-mAbs Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhabdomyosarcoma | 7 |
| Neuroblastoma | 5 |
| Sarcoma | 5 |
| Sarcoma, Ewing | 4 |
| Desmoplastic Small Round Cell Tumor | 3 |
| Medulloblastoma | 3 |
| Osteosarcoma | 3 |
| Brain Neoplasms | 2 |
| Central Nervous System Neoplasms | 2 |
| Glioma | 2 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.